Egetis: Licensing agreement opens the path to Japan - Redeye

Redeye provides an additional comment on the recent news that Egetis has outlicensed the rights to Emcitate in Japan to Fujimoto. We argue that Egetis now has a credible strategy in Japan in place and see the deal as a confirmation of the merits of focusing on partnerships in regions beyond the US and EU.

Länk till analysen i sin helhet: https://www.redeye.se/research/959841/egetis-licensing-agreement-opens-the-path-to-japan?utm_source=finwire&utm_medium=RSS